Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating whether androgen deprivation enhances PSMA PET imaging in localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Collection of Blood in Studying Metabolites in Patients With Prostate Cancer
The trial 'Collection of Blood in Studying Metabolites in Patients With Prostate Cancer' sponsored by the University of Southern California …
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load [Phase 2]
A Phase 2 trial of durvalumab plus olaparib for prostate cancer in men predicted to have a high neoantigen load was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
This clinical trial update analyzes available data to determine how closely patients with prostate cancer on second-generation androgen rece…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer [Phase 3]
Phase 3 trial results evaluate adding darolutamide to androgen-deprivation therapy versus ADT alone in metastatic hormone-sensitive prostate…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer [EARLY_Phase 1]
This early-phase 1 trial compares a non-fucosylated anti-CTLA-4 antibody (BMS-986218) plus degarelix acetate versus degarelix acetate alone …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP) [Phase 2, Phase 3]
A Phase 2/3 trial comparing Robotic-arm Assisted 68Ga PSMA PET/CT guided prostate biopsy to MR-directed cognitive fusion TRUS guided biopsy …
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating QLH12016 in combination with a novel hormonal agent for advanced prostate cancer, with the study not yet…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents [Phase 1]
Phase 1 clinical trial evaluating PSMA-targeted intraoperative fluorescent imaging agents in prostate cancer patients undergoing radical pro…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer [Phase 2]
Phase 2 trial update reporting results for systemic and tumor-directed therapy in newly diagnosed oligometastatic prostate cancer; results w…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) [NA]
The ALLSTAR trial is a randomized study evaluating strategies to increase physical activity in Black and Hispanic survivors of breast and pr…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating safety and tolerability of NOX66 in combination with palliative radiotherapy in men with late-stage prosta…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate [Phase 3]
Phase 3 study evaluating 6-month subcutaneous triptorelin in adult men with prostate cancer. The trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)
The ASPIRE study investigates active surveillance in prostate cancer. It uses imaging to detect radiographic progression as an endpoint.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging [Phase 2]
A Phase 2 clinical trial comparing 68Ga-RM2 PET/CT to 68Ga-PSMA-617 PET/CT for imaging in intermediate-risk prostate cancer has been complet…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy [Phase 2]
A Phase 2 clinical trial update evaluating whether a human amnion membrane allograft can promote early return of erectile function after rad…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies [Phase 1]
This Phase 1 study of NP-G2-044, a metastasis inhibitor, in patients with advanced or metastatic treatment-refractory solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Micro-ultrasound for Prostate Cancer Diagnosis [NA]
This clinical trial update shows that the study evaluating micro-ultrasound for prostate cancer diagnosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating Ga-68 DOTATATE PET/CT for diagnosing metastatic castration-resistant prostate cancer has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging [EARLY_Phase 1]
A completed Phase 1 pilot study evaluating whether androgen deprivation therapy influences the sensitivity of PSMA-PET imaging for staging a…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
A completed clinical trial evaluating how a treatment affected work experience in patients with stage I–III prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Tivozanib + Enzalutamide in Adv Prostate Cancer [Phase 2]
Phase 2 trial evaluating tivozanib in combination with enzalutamide for advanced prostate cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer [Phase 3]
A Phase 3 trial evaluating the efficacy of [18F]PSMA-1007 PET/CT in biochemically recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC) [Phase 1]
A Phase 1 trial evaluating BI-836845 in combination with Enzalutamide for castration-resistant prostate cancer has completed, and results ha…